Richard Lipscombe
Net worth: 2 M $ as of 2026-05-30
Net worth: 2 M $ as of 2026-05-30
Richard Lipscombe is the founder of Proteomics International Pty Ltd., founded in 2001.
Dr. Lipscombe was the founder of Proteomics International Laboratories Ltd., founded in 2014, and held the title of Managing Director & Director from 2014 to 2026.
Former job includes Manager-Core Protein Analysis Facility at The University of Western Australia.
Education includes a doctorate from the University of London, an undergraduate degree conferred in 1989, and a graduate degree conferred in 1990 from Corpus Christi College, Oxford.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-02-22 | 17,146,855 ( 10.38% ) | 2 M $ | 2026-05-30 |
| Companies | Position | End |
|---|---|---|
| PROTEOMICS INTERNATIONAL LABORATORIES LTD | Founder | 2026-01-18 |
The University of Western Australia
The University of Western Australia Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Proteomics International Pty Ltd.
Proteomics International Pty Ltd. BiotechnologyHealth Technology Operates as medical technology company that provides predictive diagnostics and bio-analytical services | Founder | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Western Australia
The University of Western Australia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corpus Christi College, Oxford
Corpus Christi College, Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd. Medical/Nursing ServicesHealth Services Provides biological research and drug discovery services | Health Services |
Proteomics International Pty Ltd.
Proteomics International Pty Ltd. BiotechnologyHealth Technology Operates as medical technology company that provides predictive diagnostics and bio-analytical services | Health Technology |
Select your edition
All financial news and data tailored to specific country editions